Robert K. Zeldin
Known title: CHIEF MEDICAL OFFICERCIK: 0001745347
Robert K. Zeldin's purchase track record
Robert K. Zeldin has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 6/3/2022 | MGTX | $39K | +12.4% | -19.8% | -0.9% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| MGTX | ▲ Buy | Option Exercise | 7,500 | — | 2/21/2026 | View on chart |
| MGTX | ▼ Sell | Tax Withholding | 2,952 | $22K | 2/21/2026 | View on chart |
| MGTX | ▲ Buy | Option Exercise | 35,000 | — | 1/17/2026 | View on chart |
| MGTX | ▼ Sell | Tax Withholding | 13,951 | $104K | 1/17/2026 | View on chart |
| MGTX | ▲ Buy | Option Exercise | 17,500 | — | 1/7/2026 | View on chart |
| MGTX | ▼ Sell | Tax Withholding | 6,729 | $52K | 1/7/2026 | View on chart |
| MGTX | ▼ Sell | Tax Withholding | 5,903 | $43K | 2/21/2025 | View on chart |
| MGTX | ▲ Buy | Option Exercise | 15,000 | — | 2/21/2025 | View on chart |
| MGTX | ▲ Buy | Option Exercise | 37,500 | — | 1/14/2025 | View on chart |
| MGTX | ▼ Sell | Tax Withholding | 15,149 | $87K | 1/14/2025 | View on chart |
| MGTX | ▲ Buy | Option Exercise | 17,500 | — | 1/7/2025 | View on chart |
| MGTX | ▼ Sell | Tax Withholding | 6,886 | $44K | 1/7/2025 | View on chart |
| MGTX | ▼ Sell | Tax Withholding | 14,756 | $94K | 1/14/2024 | View on chart |
| MGTX | ▲ Buy | Option Exercise | 37,500 | — | 1/14/2024 | View on chart |
| MGTX | ▲ Buy | Option Exercise | 35,000 | — | 1/7/2024 | View on chart |
| MGTX | ▼ Sell | Tax Withholding | 18,507 | $117K | 1/7/2024 | View on chart |
| MGTX | ▼ Sell | Tax Withholding | 29,513 | $206K | 1/14/2023 | View on chart |
| MGTX | ▲ Buy | Option Exercise | 75,000 | — | 1/14/2023 | View on chart |
| MGTX | ▲ Buy | Open Market | 4,994 | $39K | 6/3/2022 | View on chart |
| MGTX | ▲ Buy | Open Market | 6 | $47 | 6/3/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 25, 2026
Goldman Sachs initiates MeiraGTx coverage with Neutral rating
Goldman Sachs has started covering MeiraGTx, assigning a Neutral rating and a price target of $16. This new analyst view comes as the company also appointed Alan M. Sebulsky to its board of directors. The stock is currently trading near its 52-week low, providing context for the firm's initial assessment.
Goldman Sachs initiates MeiraGTx coverage with Neutral rating. Goldman Sachs has started covering MeiraGTx, assigning a Neutral rating and a price target of $16. This new analyst view comes as the company also appointed Alan M. Sebulsky to its board of directors. The stock is currently trading near its 52-week low, providing context for the firm's initial assessment.